Founded in 2007, Klea Holding is a group focused on acquiring, developing and digitizing companies in various sectors to maximize their growth and value. Through its "scaling industries of the future" identity, Klea Holding draws on its successful experience in developing Smart Salem, the first network of digitalized medical analysis centers accredited by the Dubai Ministry of Health (DHA) in the United Arab Emirates, its joint venture Smart Health, dedicated to the roll-out of digital medical testing centres in Saudi Arabia; and Klea Pharmaceuticals, a subsidiary dedicated to the commercialisation of a portfolio of licensed medicines in the Middle East and Africa.

Employees

128

Sector

Healthcare Facilities & Services

More about the company

Quotes

Date	Price	Change	Volume
23/06/26	€0.1846	-0.22%	88,224
22/06/26	€0.1850	-1.49%	406,547
19/06/26	€0.1878	-0.63%	48,597
18/06/26	€0.1890	+1.29%	170,013
17/06/26	€0.1866	-1.79%	58,788

Real-time Euronext Paris

More quotes

Income Statement and Estimates

More financial data

Annual profits - Rate of surprise

Company calendar

Real-time Euronext Paris Other stock markets 14:00:33 23/06/2026 BST			5-day change	1st Jan Change
0.1846 ^EUR	-0.22%		-2.84%	-15.71%

06-11	Klea Holding SA Announces the Launch of Its New Subsidiary, Klea Pharmaceuticals	CI
06-11	Klea Launches Medicine Distribution Business for Middle East, Africa	MT

Market Cap	56.79M 65M 52.53M 49.03M 92.05M 6.14B 92.72M 624M 243M 3.02B 244M 239M 10.49B	P/E 2024	44.3x	P/E 2025	31.3x
Enterprise Value	56.92M 65.14M 52.65M 49.14M 92.25M 6.16B 92.93M 626M 243M 3.03B 245M 239M 10.51B	EV / Sales 2024	3.3x	EV / Sales 2025	3.04x
Free-Float	99.83%	Yield 2024 *	-	Yield 2025	-

06-11	Klea Holding SA Announces the Launch of Its New Subsidiary, Klea Pharmaceuticals	CI
06-11	Klea Launches Medicine Distribution Business for Middle East, Africa	MT
06-11	Klea Holding announces the launch of its new subsidiary
04-23	Klea Holding SA Reports Earnings Results for the Full Year Ended December 31, 2025	CI
04-01	Klea Holding Establishes Klea Pharmaceuticals and Expands Healthcare Operations in Middle East and Africa	CI
03-31	Klea Holding SA acquired New Licences and Pharmaceutical Assets for AED 8.5 million.	CI
01-19	Klea Holding Increases Annual Revenue by 28%
01-19	Klea Holding SA Reports Unaudited Consolidated Sales Results for the Year Ended December 31, 2025	CI
01-19	Klea Holding SA to Open First Digital Medical Centre in Saudi Arabia in March/April 2026	CI
27/10/25	Klea Holding Strengthens Its Presence in Dubai with Its First Strategic Real Estate Investment in the Lumena Alta Project	CI
27/10/25	Klea Holding Buys Office Space at Skyscraper Project in Dubai	MT
18/09/25	Klea Holding SA Reports Earnings Results for the Half Year Ended June 30, 2025	CI
18/08/25	Klea Holding SA commences an Equity Buyback Plan for 30,751,431 shares, representing 10% of its issued share capital for ?46.13 million, under the authorization approved on June 10, 2025.	CI

06-11	Klea Holding : Klea Pharmaceuticals launch its business with a strong partner	AT
04-23	Klea : reports record results in 2025 and demonstrates remarkable resilience in Q1 2026	PU
04-23	Klea Holding : Klea Holding reports record results in 2025 and demonstrates remarkable resilience in Q1 2026	AT
04-01	Klea Holding : Klea Holding is accelerating its diversification into the healthcare sector with the creation of Klea Pharmaceuticals	AT
01-19	Klea Holding : Klea Holding reports profitable growth of 34% in turnover in 2025 at constant exchange rates	AT

Klea Holding Share Price

Stocks

ALKLH

FR0013481835

Healthcare Facilities & Services

Valuation: Klea Holding

Chart: Klea Holding

Latest news : Klea Holding

Analysts' recommendations: Klea Holding

Press Releases: Klea Holding

News in other languages: Klea Holding

Quotes and Performance

Course Extremes

Managers and Directors: Klea Holding

Latest insider transactions

Other Healthcare Facilities & Services

Financials

Company Profile

Quotes

Income Statement and Estimates

Annual profits - Rate of surprise

06-12	Klea Holding : Déclaration des transactions sur actions propres
06-11	Bourse : J-1 avant SpaceX, Oracle à la peine, contrat pour Airbus
06-11	Klea Holding annonce le démarrage de sa nouvelle filiale
06-11	Une bonne grosse purge avant SpaceX
06-11	Klea Holding : Klea Pharmaceuticals annonce le démarrage de son activité avec un puissant partenaire

1 day	-0.22%
1 week	-2.84%
Current month	-6.20%
1 month	-2.84%
3 months	+7.95%
6 months	-19.39%
Current year	-15.71%

1 week	0.18	0.19
1 month	0.18	0.2
Current year	0.15	0.25
1 year	0.15	0.31
3 years	0.15	0.54
5 years	0.08	0.59
10 years	0.08	172.4

Manager	Title	Age	Since
Clement Pacaud CEO	Chief Executive Officer	36	21/01/2024
Jérôme Fabreguettes-Leib IRC	Investor Relations Contact	-	-
Thomas Picquette CEO	Chief Executive Officer	-	31/03/2022

Director	Title	Age	Since
Guillaume Bremond CHM	Chairman	-	-
Anne Gaignard BRD	Director/Board Member	-	31/03/2022
Paul Amsellem BRD	Director/Board Member	51	13/06/2023

Date	Insider	Type	Quantity	% Market Cap.
03-10	Raphael Smila	Buy	40,000	0.0130%
03-10	Raphael Smila	Buy	95,000	0.0309%
03-10	Raphael Smila	Buy	10,000	0.0033%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
KLEA HOLDING	-0.22%	-2.84%	+4.89%	-65.40%	65M
CVS HEALTH CORPORATION	+3.03%	+0.62%	+52.17%	+45.94%	129B
HCA HEALTHCARE, INC.	+0.49%	-3.33%	-0.14%	+28.05%	83.63B
FRESENIUS SE & CO. KGAA	+0.57%	+2.42%	-4.93%	+57.64%	25.49B
QUEST DIAGNOSTICS INCORPORATED	-0.73%	-4.25%	+7.89%	+39.48%	21.43B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	-0.47%	-2.61%	-15.07%	-27.05%	19.95B
TENET HEALTHCARE CORPORATION	+3.58%	-0.20%	+6.39%	+125.64%	15.4B
REDE D'OR SÃO LUIZ S.A.	+0.68%	+0.09%	-2.79%	+2.73%	14.5B
DAVITA INC.	+0.85%	-0.03%	+53.12%	+111.88%	13.46B
FRESENIUS MEDICAL CARE AG	+0.97%	+1.41%	-11.05%	-7.20%	12.68B
Average	+0.65%	-1.03%	+9.05%	+31.17%	33.58B
Weighted average by Cap.	+0.64%	-1.28%	+21.16%	+40.03%

	2024	2025
Net sales	17.26M 19.75M 15.97M 14.9M 27.97M 1.87B 28.18M 190M 73.82M 918M 74.16M 72.55M 3.19B	22.17M 25.37M 20.5M 19.14M 35.93M 2.4B 36.19M 244M 94.8M 1.18B 95.24M 93.18M 4.09B
Net income	1.4M 1.61M 1.3M 1.21M 2.28M 152M 2.29M 15.44M 6.01M 74.71M 6.04M 5.91M 260M	2.28M 2.61M 2.11M 1.97M 3.7M 247M 3.72M 25.07M 9.76M 121M 9.8M 9.59M 421M
Net Debt	2.58M 2.95M 2.38M 2.22M 4.17M 278M 4.2M 28.3M 11.01M 137M 11.06M 10.82M 476M	125K 143K 116K 108K 203K 13.52M 204K 1.37M 535K 6.65M 537K 525K 23.09M